Hanny Al-Samkari, MD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed ·

Quick facts

Marketed products

Bevacizumab (Avastin®) · Oncology
Bevacizumab is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), preventing new blood vessel formation that tumors need to grow.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Hanny Al-Samkari, MD portfolio CI brief
Hanny Al-Samkari, MD pipeline updates RSS

Frequently asked questions about Hanny Al-Samkari, MD

What are Hanny Al-Samkari, MD's marketed drugs?

Top marketed products include Bevacizumab (Avastin®).

Bevacizumab (Avastin®) · Oncology
Sector hub: All tracked pharma companies